Ten-year incidence of gross proteinuria in people with diabetes

Diabetes

Volumn 44, Issue 8, 1995, Pages 916-923

  Klein, Ronald ^a   Klein, Barbara E K ^a   Moss, Scot E ^a   Cruickshanks, Karen J ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

EID: 0029151864     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.44.8.916     Document Type: Article

References (25)

1. Herman WH, Teutsch SM: Kidney diseases associated with diabetes. In Diabetes in America. Harris MI, Hamman RF, Eds. Bethesda, MD, US Dept. of Health and Human Services, 1985, p. XIV1-XIV31
2. Eggers PW, Connerton R, MuMullon M: The Medicare experience with end-stage renal disease: trends in incidence, prevalence, and survival. Health Care Financing Rev 5:69-88, 1984
3. Geiss LS, Herman WH, Teutsch SM: Diabetes and renal mortality in the United States. Am J Public Health 75:1325-1326, 1985
4. Nelson RG, Pettitt DJ, Carraher MJ, Baird HR, Knowler WC: Impact of proteinuria on mortality in NIDDM. Diabetes 37:1499-1504, 1988
5. Moss SE, Klein R, Klein BEK: Cause-specific mortality in a population-based study of diabetes. Am J Public Health 81:1158-1162, 1991
6. Biesenbach G, Zazgornik J: High mortality and poor quality of life during predialysis period in type D. diabetic patients with diabetic nephropathy. Renal Failure 16:263-272, 1994
7. Shyh T-P, Beyer MM, Friedman EA: Treatment of the uremic diabetic. Nephron 40:129-138, 1985
8. Viberti GC, Walker JD, Pinto J: Diabetic nephropathy. In International Textbook of Diabetes Mellitus. Vol. 2. Alberti KGMM, DeFronzo RA, Keen H, Zimmet P, Eds. West Sussex, England, Wiley, 1992, p. 1267-1328
9. Reichard P, Nilsson B-Y, Rosenqvist U: The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329:304-309, 1993
10. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
11. Marre M, Chatellier G, Leblanc H, Guyene TT, Menard J, Passa P: Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria, Br Med J 297:1092-1095, 1988
12. Mathiesen ER, Hommel E, Giese J, Parving H-H: Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. Br Med J 303:81-87, 1991
13. Klein R, Klein BEK, Moss SE: The incidence of gross proteinuria in people with insulin-dependent diabetes mellitus. Arch Intern Med 151:1344-1348, 1991
14. Bollard DJ, Humphrey LL, Melton LJ III, Frohnert PP, Chu C-P, O'Fallon WM, Palumbo PJ: Epidemiology of persistent proteinuria in type II diabetes mellitus: population-based study in Rochester, Minnesota. Diabetes 37:405-412, 1988
15. Sasaki A, Horiuchi N, Hasagawa K, Uehara M: Persistent albuminuria as an index of diabetic nephropathy in type 2 diabetic patients in Osaka, Japan: incidence, risk factors, prognosis and cause of death. Diabetes Res Clin Proc 7:289-306, 1989
16. Klein R, Klein BEK, Moss SE: Incidence of gross proteinuria in older-onset diabetes: a population-based perspective. Diabetes 42:381-389, 1993
17. Klein R, Klein BEK, Moss SE, DeMets DL, Kaufman I, Voss PS: Prevalence of diabetes mellitus in southern Wisconsin. Am J Epidemiol 119:54-61, 1984
18. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is <30. Arch Ophthalmol 102:520-526, 1984
19. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102:527-532, 1984
20. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is <30 years. Arch Ophthalmol 107:237-243, 1989
21. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 107:244-249, 1989
22. Klein R, Klein BEK, Moss SE, Cruickshanks KJ: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 112:1217-1228, 1994
23. Hypertension Detection and Follow-up Program Cooperative Group: The hypertension detection and follow-up program. Prev Med 5:207-215, 1976
24. Early Treatment Diabetic Retinopathy Study: Manual of Operations. Chaps. 12 and 18. Baltimore, MD, ETDRS Coordinating Center, Dept of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, 1985
25. Quick-Step, Fast Hemoglobin Test System. Akron, OH, Isolab, 1981